TrialTrials2026

Efficacy and safety of remimazolam for sedation of patients with end-stage renal disease: a prospective, randomized controlled clinical trial.

Jie Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.